Article

Topical nanoemulsion therapy reduces bacterial wound infection and inflammation after burn injury

Department of Surgery, University of Michigan Medical School, Ann Arbor, MI 48109-5033, USA.
Surgery (Impact Factor: 3.11). 02/2010; 148(3):499-509. DOI: 10.1016/j.surg.2010.01.001
Source: PubMed

ABSTRACT Nanoemulsions are broadly antimicrobial oil-in-water emulsions containing nanometer-sized droplets stabilized with surfactants. We hypothesize that topical application of a nanoemulsion compound (NB-201) can attenuate burn wound infection. In addition to reducing infection, nanoemulsion therapy may modulate dermal inflammatory signaling and thereby lessen inflammation following thermal injury.
Male Sprague-Dawley rats underwent a 20% total body surface area scald burn to create a partial-thickness burn injury. Animals were resuscitated with Ringer's lactate solution and the wound covered with an occlusive dressing. At 8 hours after injury, the burn wound was inoculated with 1 x 10(6) colony-forming units (CFUs) of Pseudomonas aeruginosa. NB-201, NB-201 placebo, 5% mafenide acetate solution, or 0.9% saline (control) was applied onto the wound at 16 and 24 hours after burn injury. Skin was harvested 32 hours postburn for quantitative wound culture and determination of inflammatory mediators in tissue homogenates.
NB-201 decreased mean bacterial growth in the burn wound by 1,000-fold, with only 13% (3/23) of animals having P. aeruginosa counts greater than 10(5) CFU/g tissue versus 91% (29/32) in the control group (P < .0001). Treatment with NB-201 attenuated neutrophil sequestration in the treatment group as measured by myeloperoxidase assay and by histology. It also significantly decreased levels of proinflammatory cytokines (interleukin [IL]-1beta and IL-6) and the degree of hair follicle cell apoptosis in skin compared to saline-treated controls.
Topical NB-201 substantially decreased bacterial growth in a partial-thickness burn model. This decrease in the level of wound infection was associated with an attenuation of the local dermal inflammatory response and diminished neutrophil sequestration. NB-201 represents a novel potent antimicrobial and anti-inflammatory treatment for use in burn wounds.

Full-text

Available from: James R Baker, May 30, 2015
1 Follower
 · 
179 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Burn injury is a severe form of trauma affecting more than 2 million people in North America each year. Burn trauma is not a single pathophysiological event but a devastating injury that causes structural and functional deficits in numerous organ systems. Due to its complexity and the involvement of multiple organs, in vitro experiments cannot capture this complexity nor address the pathophysiology. In the past two decades, a number of burn animal models have been developed to replicate the various aspects of burn injury, to elucidate the pathophysiology, and to explore potential treatment interventions. Understanding the advantages and limitations of these animal models is essential for the design and development of treatments that are clinically relevant to humans. This review aims to highlight the common animal models of burn injury in order to provide investigators with a better understanding of the benefits and limitations of these models for translational applications. While many animal models of burn exist, we limit our discussion to the skin healing of mouse, rat, and pig. Additionally, we briefly explain hypermetabolic characteristics of burn injury and the animal model utilized to study this phenomena. Finally, we discuss the economic costs associated with each of these models in order to guide decisions of choosing the appropriate animal model for burn research.
    Cellular and Molecular Life Sciences CMLS 04/2014; DOI:10.1007/s00018-014-1612-5 · 5.86 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Different materials in form of sponge, hydrogel and film have been developed and formulated for treating and dressing burn wounds. In this study, the potential of Laponite, a gel forming clay, in combination with an antimicrobial agent (mafenide), as a wound dressing material was tested in vitro. Laponite/mafenide (Lap/Maf) hydrogel was formulated in three different ratios of Lap/Maf 1:1, 1:2, 1:3. Laponite/mafenide/alginate (Lap/Maf/Alg) film was also formulated by combining Lap/Maf gel (1:1) with alginate. Intercalation rate of mafenide into the layers of Laponite nanoparticles and physico-chemical properties, including wound dressing characteristics of materials were studied using various analytical methods. Furthermore, the degradation of materials and the release profile of mafenide were investigated in simulated wound exudates fluid and antibacterial effectiveness of the eluted mafenide was tested on a range of bacterial species. The cytotoxicity of materials was also evaluated in skin fibroblast culture. The results showed that mafenide molecules were intercalated between the nano-sized layers of Laponite. The eluted mafenide showed active antibacterial effects against all three tested bacteria. All intercalated mafenide released from Lap/Maf 1:1 and 1:2 gel formulations and nearly 80 % release from 1:3 formulation during test period. No significant difference was observed in release profile of mafenide between Lap/Maf/Alg film and Lap/Maf formulations. Wound dressing tests on Lap/Maf/Alg film showed it is a breathable dressing and has capacity to absorb wound exudates. The study showed that prepared Lap/Maf composite has the potential to be used as an antibiotic eluting gel or film for wound healing application. Additionally, Laponite has shown benefits in wound healing processes by releasing Mg(2+) ions and thereby reducing the cytotoxic effect of mafenide on fibroblast cells.
    Journal of Materials Science Materials in Medicine 07/2014; 25(11). DOI:10.1007/s10856-014-5272-7 · 2.38 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Burn injury is damage to the skin or other body parts caused by extreme heat, flame, or contact with heated objects or chemicals. The World Health Organization estimated that 322000 people die each year from fire related burns with >95% of these occurred in developing countries. In UK, it accounted for 175000 emergency department attendances and 15000 admissions. A further 250000 patient were managed in the community by general practitioners and allied professionals. A survey in 1998 showed that up to 58% of UK ambulance services had no specific treatment policy for burn patients. In Ireland and Australia, only 23% and 39% respectively, had employed the correct first aid burn management in studies conducted on their primary carers. Early burn management, from the moment of contact to eventual hospital arrival, are important to reduce the potential morbidity and mortality of burn victims. The initial management of burn from removal of patients from zone of incident to the topical administration of cool water has been shown to significantly reduce the extent of injury of burn patients. Further critical and timely assessment and management of these patients, pre-hospital and on arrival to emergency department, improve their chances of survival through adequate airway management and resuscitation. The need for emergency surgical procedure from emergency department to operating theatre should also be instituted when warranted without delay. Here, we review the pathophysiological rationale and evidence of practice behind each of these steps, from the first aid burn treatment to their assessment and resuscitation, and finally emergency procedure, together with their ancillary treatment, in practice.
    Burns: Prevention, Causes and Treatment, First edited by Emily S. McLaughlin, Ava O. Paterson, 08/2012: chapter One: pages 1-38; Nova Publishers., ISBN: 978-1-62100-446-2